IMI is a unique Public-Private Partnership (PPP) between the pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the European Communities represented by the European Commission. The First Call of the IMI Joint Undertaking was launched by European Commissioner for Science and Research Janez Potočnik and EFPIA President Arthur Higgins on April 30. and Táňa Perglová.